Direkt zum Inhalt
Merck

Recovery of neutrophil apoptosis by ectoine: a new strategy against lung inflammation.

The European respiratory journal (2012-10-27)
Ulrich Sydlik, Henrike Peuschel, Adnana Paunel-Görgülü, Stefanie Keymel, Ursula Krämer, Alexander Weissenberg, Matthias Kroker, Samira Seghrouchni, Christian Heiss, Joachim Windolf, Andreas Bilstein, Malte Kelm, Jean Krutmann, Klaus Unfried
ZUSAMMENFASSUNG

The life span of neutrophilic granulocytes has a determining impact on the intensity and duration of neutrophil driven lung inflammation. Based on the compatible solute ectoine, we aimed to prevent anti-apoptotic reactions in neutrophils triggered by the inflammatory microenvironment in the lung. Neutrophils from chronic obstructive pulmonary disease patients and control individuals were exposed to inflammatory mediators and xenobiotics in the presence or absence of ectoine. The in vivo relevance of this approach was tested in xenobiotic-induced lung inflammation in rats. The reduction of apoptosis rates of ex vivo-exposed neutrophils from all study groups was significantly restored in the presence of ectoine. However, natural apoptosis rates not altered by inflammatory stimuli were not changed by ectoine. Mechanistic analyses demonstrated the preventive effect of ectoine on the induction of anti-apoptotic signalling. Neutrophilic lung inflammation induced by single or multiple expositions of animals to environmental particles was reduced after the therapeutic intervention with ectoine. Analyses of neutrophils from bronchoalveolar lavage indicate that the in vivo effect is due to the restoration of neutrophil apoptosis. Ectoine, a compound of the highly compliant group of compatible solutes, demonstrates a reproducible and robust effect on the resolution of lung inflammation.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Ectoin, osmoprotectant
Sigma-Aldrich
Ectoin, ≥95.0% (HPLC)